These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18808308)

  • 21. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
    Igari M; Alexander JC; Ji Y; Qi X; Papke RL; Bruijnzeel AW
    Neuropsychopharmacology; 2014 Jan; 39(2):455-65. PubMed ID: 23966067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
    Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
    J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
    Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
    JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytisine for smoking cessation.
    Karnieg T; Wang X
    CMAJ; 2018 May; 190(19):E596. PubMed ID: 29759967
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.
    Oreskovic T; Percac-Lima S; Ashburner JM; Tiljak H; Rifel J; Klemenc Ketiš Z; Oreskovic S
    Nicotine Tob Res; 2023 Aug; 25(9):1547-1555. PubMed ID: 37291049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
    McCaul ME; Wand GS; Kuwabara H; Dannals RF; Wong D; Xu X
    Nicotine Tob Res; 2020 May; 22(6):892-899. PubMed ID: 31096265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytisine versus nicotine for smoking cessation.
    Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
    N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
    Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An uncontrolled trial of cytisine (Tabex) for smoking cessation.
    Zatonski W; Cedzynska M; Tutka P; West R
    Tob Control; 2006 Dec; 15(6):481-4. PubMed ID: 17130378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real life.
    Pozzi P; Boffi R; Veronese C; Trussardo S; Valsecchi C; Sabia F; Pastorino U; Apolone G; Cardani E; Tarantini F; Munarini E
    Tumori; 2024 Apr; 110(2):124-131. PubMed ID: 38149659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.